Track topics on Twitter Track topics that are important to you
Coventry, UK, 21st May 2019 / Sciad Newswire / Medherant Limited (“Medherant”), the clinical-stage developer of innovative transdermal delivery products for pain and CNS diseases using its uniq...
Coventry, UK, 25th June 2019 / Sciad Newswire / Medherant Limited (“Medherant”), the clinical-stage company developing innovative products for pain and CNS diseases using a unique transdermal d...
Coventry, UK, 5th November 2018 / Sciad Newswire / Medherant, a developer of innovative transdermal drug delivery treatments for pain and CNS diseases, has successfully completed two Phase I studie...
New funding to support manufacture of transdermal patches for clinical trials Coventry, UK, 3rd October 2018 / Sciad Newswire / Medherant, a developer of innovative transdermal drug delivery treatme...
John Burt will replace Current CEO, Nigel Davis, who will stay on as Chief Business Officer
Funding for the Warwick University spinout is part of around Â£2.4m syndicated investment round
Medherant Ltd is a leading developer of next-generation transdermal drug delivery patches. Its TEPI PatchÂ® technology can:
We have published hundreds of Medherant news stories on BioPortfolio along with dozens of Medherant Clinical Trials and PubMed Articles about Medherant for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Medherant Companies in our database. You can also find out about relevant Medherant Drugs and Medications on this site too.
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...